US Stocks
/
Minerva Neurosciences, Inc Share Price

Minerva Neurosciences, Inc Share Price

NASDAQ: NERV | Micro Cap
$4.63
+$0.41 (9.72%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Minerva Neurosciences, Inc Stock Performance

Open
$4.32
Prev. Close
$4.22
Circuit Range
N/A
Day Range
$4.30 - $4.65
Year Range
$1.95 - $12.28
Volume
7,367
Average Traded
$4.53

Minerva Neurosciences, Inc Share Price Today

As of 11 August 2026, Minerva Neurosciences, Inc's share price is $4.63. The stock opened at $4.32, compared to its previous close of $4.22. During today's trading session, Minerva Neurosciences, Inc's share price traded between $4.30 and $4.65, with an average price of $4.47. Over the past 52 weeks, the stock has recorded a high of $12.28 and a low of $1.95. In terms of performance, Minerva Neurosciences, Inc's share price has declined by 29.69% over the last six months and is up 96.85% on a year-on-year basis.

Minerva Neurosciences, Inc Share Price Chart

$4.30$4.65
L
Show Current Price
H

Minerva Neurosciences, Inc Stock Fundamentals & Key Indicators

Market Cap
$39.19M
PE Ratio (TTM)
-0.13
Dividend Yield
N/A
EPS (TTM)
$-34.67
Revenue (TTM)
N/A
Return On Equity (TTM)
208.47%
Profit Margin
N/A
Debt to Equity
-0.02
Quarterly Earnings Growth YoY
-112.19%

Minerva Neurosciences, Inc Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$8.57M-$8.23M$22.51M-$3.75M-$3.26M-$2.74M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A3.91%373.43%-116.67%13.17%15.79%

Minerva Neurosciences, Inc Annual Profit & Loss

All figures in USD

Particulars2025
RevenueN/A
Net Profit-$293.42M
Net Profit MarginN/A
Income ChangeN/A

About Minerva Neurosciences, Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Minerva Neurosciences, Inc Historical Returns

MonthOpenCloseChange %
Aug 2026
$4.04
$4.62
+16.37%
Jul 2026
$5.43
$3.97
-28.73%
Jun 2026
$4.92
$5.57
+12.98%
May 2026
$6.38
$4.93
-23.45%
Apr 2026
$6.16
$6.44
+6.36%
Mar 2026
$6.23
$6.05
-8.05%
Feb 2026
$4.20
$6.58
+57.91%
Jan 2026
$4.01
$4.17
+0.97%
Dec 2025
$4.17
$4.13
+7.55%
Nov 2025
$3.99
$3.84
-8.90%
Oct 2025
$2.10
$4.21
+96.05%
Sep 2025
$2.34
$2.15
-8.59%

NERV Share Price FAQs

What is Minerva Neurosciences, Inc share price today?

chevron-up
Minerva Neurosciences, Inc share price today is $4.63 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Minerva Neurosciences, Inc stock?

chevron-up
The 52 week high of Minerva Neurosciences, Inc stock is $12.28, while the 52 week low is $1.95 as of 11 Aug '26.

What is NERV's market capitalisation today?

chevron-up
NERV market capitalisation is $39.19M as of August 11, 2026, at 7:12 am IST.

What is NERV's net income for the last quarter?

chevron-up
NERV's net income for the last quarter is -0.00B USD.

What is the 5 year returns of NERV?

chevron-up
The 5 year returns of NERV is -68.55% as on 11 Aug '26.

What is the high & low stock price of NERV today?

chevron-up
NERV stock price hit a high of $4.65 and low of $4.30 as of 11 Aug '26.

Can I buy NERV shares in India?

chevron-up
Yes. You can buy NERV in India by opening an international trading account.